Cargando…
Targeting the immune milieu in gastrointestinal cancers
Gastrointestinal (GI) cancers are among the most common and lethal solid tumors worldwide. Unlike in malignancies such as lung, renal and skin cancers, the activity of immunotherapeutic agents in GI cancers has, on the whole, been much less remarkable and do not apply to the majority. Furthermore, w...
Autores principales: | Turkes, Fiona, Mencel, Justin, Starling, Naureen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519898/ https://www.ncbi.nlm.nih.gov/pubmed/32748171 http://dx.doi.org/10.1007/s00535-020-01710-x |
Ejemplares similares
-
The Role of ctDNA in Gastric Cancer
por: Mencel, Justin, et al.
Publicado: (2022) -
Contemporary Tailored Oncology Treatment of Biliary Tract Cancers
por: Turkes, Fiona, et al.
Publicado: (2019) -
The Next Frontier in Pancreatic Cancer: Targeting the Tumor Immune Milieu and Molecular Pathways
por: Yin, Chao, et al.
Publicado: (2022) -
Targeted Therapies and Developing Precision Medicine in Gastric Cancer
por: Pihlak, Rille, et al.
Publicado: (2023) -
Targeting FGFR2 Positive Gastroesophageal Cancer: Current and Clinical Developments
por: Gordon, Anderley, et al.
Publicado: (2022)